Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1996 1
1997 5
1998 8
1999 3
2000 5
2001 3
2002 3
2003 10
2004 9
2005 7
2006 6
2007 12
2008 13
2009 4
2010 4
2011 10
2012 11
2013 11
2014 7
2015 8
2016 2
2017 4
2018 6
2019 4
2020 8
2021 15
2022 11
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Post-intensive care unit follow-up: don't stop it now!
Rousseau AF, Minguet P, Neis-Gilson S, Misset B, Lambermont B. Rousseau AF, et al. Among authors: lambermont b. Intensive Care Med. 2024 May 7. doi: 10.1007/s00134-024-07467-8. Online ahead of print. Intensive Care Med. 2024. PMID: 38713214 No abstract available.
Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis.
Razazi K, Luyt CE, Voiriot G, Rouzé A, Garnier M, Ferré A, Camous L, Heming N, Lapidus N, Charles-Nelson A, Mekontso-Dessap A; COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Razazi K, et al. Crit Care. 2024 Apr 20;28(1):131. doi: 10.1186/s13054-024-04906-2. Crit Care. 2024. PMID: 38641851 Free PMC article.
Systematic Review of the Key Factors Influencing the Indoor Airborne Spread of SARS-CoV-2.
de Crane D'Heysselaer S, Parisi G, Lisson M, Bruyère O, Donneau AF, Fontaine S, Gillet L, Bureau F, Darcis G, Thiry E, Ducatez M, Snoeck CJ, Zientara S, Haddad N, Humblet MF, Ludwig-Begall LF, Daube G, Thiry D, Misset B, Lambermont B, Tandjaoui-Lambiotte Y, Zahar JR, Sartor K, Noël C, Saegerman C, Haubruge E. de Crane D'Heysselaer S, et al. Among authors: lambermont b. Pathogens. 2023 Feb 27;12(3):382. doi: 10.3390/pathogens12030382. Pathogens. 2023. PMID: 36986304 Free PMC article. Review.
Characteristics of Mid-Term Post-Intensive Care Syndrome in Patients Attending a Follow-Up Clinic: A Prospective Comparison Between COVID-19 and Non-COVID-19 Survivors.
Rousseau AF, Colson C, Minguet P, Kellens I, Collard M, Vancraybex C, Guiot J, Lambermont B, Misset B. Rousseau AF, et al. Among authors: lambermont b. Crit Care Explor. 2023 Jan 18;5(1):e0850. doi: 10.1097/CCE.0000000000000850. eCollection 2023 Jan. Crit Care Explor. 2023. PMID: 36699242 Free PMC article.
Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity.
Guiot J, Maes N, Winandy M, Henket M, Ernst B, Thys M, Frix AN, Morimont P, Rousseau AF, Canivet P, Louis R, Misset B, Meunier P, Charbonnier JP, Lambermont B. Guiot J, et al. Among authors: lambermont b. Front Med (Lausanne). 2022 Aug 29;9:930055. doi: 10.3389/fmed.2022.930055. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36106317 Free PMC article.
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial.
Grégoire C, Layios N, Lambermont B, Lechanteur C, Briquet A, Bettonville V, Baudoux E, Thys M, Dardenne N, Misset B, Beguin Y. Grégoire C, et al. Among authors: lambermont b. Front Immunol. 2022 Jul 4;13:932360. doi: 10.3389/fimmu.2022.932360. eCollection 2022. Front Immunol. 2022. PMID: 35860245 Free PMC article. Clinical Trial.
183 results